Market Tracker

05/24 5:16pm ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

33.37
Delayed Data
As of May 24
 -0.71 / -2.08%
Today’s Change
30.01
Today|||52-Week Range
71.50
-46.12%
Year-to-Date
Better Buy: Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.
May 24 / MotleyFool.com - Paid Partner Content
Drawing Biopharma Concepts With A Crayon
May 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.08
Today’s open34.31
Day’s range33.07 - 34.85
Volume1,969,736
Average volume (3 months)1,849,328
Market cap$4.1B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-99.69%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book20.43

Competitors

 Today’s
change
Today’s
% change
CRLCharles River Labora...+0.92+1.09%
ICLRICON PLC+1.66+2.52%
ALNYAlnylam Pharmaceutic...+1.74+3.10%
PRXLPAREXEL Internationa...+1.81+3.04%
Data as of 4:02pm ET, 05/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts